Volume | 6,722 |
|
|||||
News | - | ||||||
Day High | 1.05 | Low High |
|||||
Day Low | 1.03 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ainos Inc | AIMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.04 | 1.03 | 1.05 | 1.0401 | 1.04 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
70 | 6,722 | $ 1.04 | $ 7,000 | - | 0.79 - 6.097 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:54:32 | 6 | $ 1.03 | USD |
Ainos Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.19M | 5.95M | - | 122k | -13.77M | -2.31 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ainos News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.0202 | 1.08 | 1.00 | 1.04 | 30,250 | 0.0199 | 1.95% |
1 Month | 1.17 | 1.28 | 1.00 | 1.12 | 68,748 | -0.1299 | -11.10% |
3 Months | 1.00 | 3.10 | 0.79 | 1.78 | 1,491,892 | 0.0401 | 4.01% |
6 Months | 3.25 | 4.2899 | 0.79 | 2.04 | 971,329 | -2.21 | -68.00% |
1 Year | 3.90 | 6.097 | 0.79 | 2.38 | 544,782 | -2.86 | -73.33% |
3 Years | 18.60 | 18.75 | 0.79 | 4.65 | 552,634 | -17.56 | -94.41% |
5 Years | 18.60 | 18.75 | 0.79 | 4.65 | 552,634 | -17.56 | -94.41% |
Ainos Description
Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company¿s products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. |